Research exploring optimal combinations of NNMT inhibition + NAD+ precursor supplementation, and understanding tissue-specific NNMT function, utilizes 5-Amino-1MQ as a research tool
Both reasons are valid but the approach, expectations, and oversight should differ accordingly
616.0 million in cash and cash equivalents and total assets of 1.30 billion
Serious athletes rehabbing injuries, larger individuals who find lower doses ineffective, or anyone wanting the option to dose up when needed
Administration less frequent than twice weekly likely allows complete dissipation of synaptic changes between doses, preventing the cumulative structural modifications that constitute Dihexas therapeutic mechanism
[1] [2] Consistency in timing helps optimise the drug's effectiveness and may help manage side effects